The CBS inhibitor CH004 decreased the cell survival of the C4-2 and PC3 PCa cell lines, but the benign prostate cell lines RWPE1 and BPH-1 were largely unaffected (Fig. 3h, j)34. The gene discussed is CBS; the disease is posterior cortical atrophy.